First Time Loading...

Chromadex Corp
NASDAQ:CDXC

Watchlist Manager
Chromadex Corp Logo
Chromadex Corp
NASDAQ:CDXC
Watchlist
Price: 3.9201 USD -0.25%
Updated: Apr 16, 2024
Section:
 

Relative Value

The Relative Value of one CDXC stock under the Base Case scenario is 3.4501 USD. Compared to the current market price of 3.9201 USD, Chromadex Corp is Overvalued by 12%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CDXC Relative Value
Base Case
3.4501 USD
Overvaluation 12%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.5
P/S
P/S
Price to Sales
3.5
vs History
55
vs Industry
51
Median 3Y
1.7
Median 5Y
4.3
Industry
3.9
Forward
3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-15.1
Median 5Y
-10.4
Industry
31.8
Forward
-287.1
More Details
41.3
P/OCF
P/OCF
Price to OCF
41.3
vs History
4
vs Industry
11
Median 3Y
-6.7
Median 5Y
-10.6
Industry
23.8
More Details
42.3
P/FCFE
P/FCFE
Price to FCFE
42.3
vs History
4
vs Industry
15
Median 3Y
-6.6
Median 5Y
-13.3
Industry
26.3
More Details
10.3
P/B
P/B
Price to Book Value
10.3
vs History
46
vs Industry
5
Median 3Y
5.4
Median 5Y
8.7
Industry
2.5
More Details
3.2
EV/S
EV/S
Enterprise Value to Sales
3.2
vs History
55
vs Industry
51
Median 3Y
1.5
Median 5Y
4
Industry
3.9
Forward
2.7
More Details
5.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.3
vs History
55
vs Industry
59
Median 3Y
2.5
Median 5Y
6.8
Industry
8.1
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-11.7
Median 5Y
-8.7
Industry
17.6
Forward
50.2
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-10.3
Median 5Y
-8.4
Industry
23
Forward
-141.1
More Details
37.5
EV/OCF
EV/OCF
Enterprise Value to OCF
37.5
vs History
4
vs Industry
12
Median 3Y
-5.9
Median 5Y
-9.4
Industry
21.7
More Details
38.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
38.3
vs History
4
vs Industry
18
Median 3Y
-5.8
Median 5Y
-9.2
Industry
27.8
More Details
15.2
EV/IC
EV/IC
Enterprise Value to IC
15.2
vs History
42
vs Industry
4
Median 3Y
5.4
Median 5Y
13.4
Industry
2.4
More Details

Multiples Across Competitors

CDXC Competitors Multiples
Chromadex Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Chromadex Corp
NASDAQ:CDXC
293.9m USD 3.5 -59.5 -58.4 -47.6
US
Thermo Fisher Scientific Inc
NYSE:TMO
214B USD 5 35.8 22.1 32.4
US
Danaher Corp
NYSE:DHR
177.1B USD 7.4 37.4 25.3 35.6
US
IQVIA Holdings Inc
NYSE:IQV
42.1B USD 2.8 30.8 16.8 26
CH
Lonza Group AG
SIX:LONN
38B CHF 5.7 58.2 28.6 28.6
US
Agilent Technologies Inc
NYSE:A
40.3B USD 6 32.6 26.1 31.4
KR
Samsung Biologics Co Ltd
KRX:207940
55.9T KRW 15.1 65.1 34.3 49.5
US
West Pharmaceutical Services Inc
NYSE:WST
27.7B USD 9.4 46.9 31.9 38.1
US
Mettler-Toledo International Inc
NYSE:MTD
26.5B USD 7 33.7 23.5 26.1
IE
ICON PLC
NASDAQ:ICLR
24.4B USD 3 39.8 17 26.5
FR
Sartorius Stedim Biotech SA
PAR:DIM
23.1B EUR 8.3 74.5 37.5 56.4

See Also

Summary
CDXC intrinsic value, competitors valuation, and company profile.
DCF Valuation
CDXC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CDXC stock valuation using valuation multiples.
Wall Street Estimates
CDXC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CDXC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 128,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.